Topadur Pharma

News

8.9.22

TOPADUR has been selected as a TOP 100 Scale-up 2022 with unicorn potential

TOPADUR Pharma AG has been selected among Switzerland's most promising scale-ups in 2022. Huge thanks to everyone of our team, supporters, and partners believing in us along the way!

Please check out the link below.

‍

Download Document Dokument herunterladen https://www.top100startups.swiss/On-the-road-to-growth-Switzerlands-most-promising-scaleups-in-2022 https://www.top100startups.swiss/On-the-road-to-growth-Switzerlands-most-promising-scaleups-in-2022

3.7.20

Press Release

Dr. Daniel L. Vasella new member of the Board of Directors

The shareholders of the company elected today Dr. Daniel L. Vasella, as new member to the Board of Directors.

24.10.24

News

Topadur Pharma AG announces CEO change

The Board of Directors of Topadur Pharma AG announces that Pascal Brenneisen will leave his position as CEO

12.8.25

Press Release

Professor Thierry Carrel, MD joins Topadur's board

Topadur Pharma AG Strengthens Board with Renowned Cardiovascular Surgeon, Professor Thierry Carrel, MD

TOPADUR has been selected as a TOP 100 Scale-up 2022 with unicorn potential

Dr. Daniel L. Vasella new member of the Board of Directors

Topadur Pharma AG announces CEO change

Professor Thierry Carrel, MD joins Topadur's board

About us

Approach

Disease Areas

Investors

Contact